| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2328065 | B | Inhibition of mouse NPC1 interaction to Ebola virus GP expressed in LE/LY membrane of CHO cells by immunoblotting | Mus musculus | 5 | cell-based format | Scientific Literature | ||
| 2. | ALA2328531 | F | Antiviral activity against Vesicular stomatitis virus by cell based luciferase reporter gene assay | Vesicular stomatitis virus | 1 | organism-based format | Scientific Literature | ||
| 3. | ALA2328532 | F | Antiviral activity against Lassa virus by cell based luciferase reporter gene assay | Mammarenavirus lassaense | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA2328533 | F | Antiviral activity against Ebola virus by cell based luciferase reporter gene assay | Ebola virus sp. | 70 | cell-based format | Scientific Literature | ||
| 5. | ALA4195608 | P | Kinetic solubility of the compound in phosphate buffered saline at pH 7.4 by HPLC analysis | 7 | small-molecule physicochemical format | Scientific Literature | |||
| 6. | ALA4195611 | A | Half life in mouse liver microsomes at 1 uM after 60 mins in presence of NADPH by LC-MS/MS analysis | Mus musculus | 7 | microsome format | Scientific Literature | ||
| 7. | ALA4195613 | A | Half life in human liver microsomes at 1 uM after 60 mins in presence of NADPH by LC-MS/MS analysis | Homo sapiens | 5 | microsome format | Scientific Literature | ||
| 8. | ALA4195632 | F | Antiviral activity against VSV pseudotyped Ebolavirus expressing M-GFP infected in African green monkey Vero E6 cells assessed as inhibition of viral infection pre-incubated for 2 hrs before infection and measured after 8 to 12 hrs by fluorescence microscopic method | Ebolavirus | 68 | assay format | Scientific Literature | ||
| 9. | ALA4195634 | F | Antiviral activity against Ebola virus - Mayinga, Zaire, 1976 infected in human HeLa cells assessed as inhibition of viral infection pretreated for 2 hrs before viral infection and measured after 48 hrs by EboV GP immunostaining based method | Ebola virus - Mayinga, Zaire, 1976 | 4 | cell-based format | Scientific Literature | ||
| 10. | ALA4195635 | F | Antiviral activity against recombinant VSV pseudotyped Ebolavirus expressing M-GFP infected in African green monkey Vero E6 cells assessed as inhibition of viral infection pre-incubated for 2 hrs before infection and measured after 8 to 12 hrs in presence of 50% NHS by fluorescence microscopic method | Ebolavirus | 8 | assay format | Scientific Literature | ||
| 11. | ALA4195636 | F | Antiviral activity against Ebolavirus isolate Makona infected in human HeLa cells assessed as inhibition of viral infection pretreated for 2 hrs before viral infection and measured after 48 hrs by EboV GP immunostaining based method | Ebolavirus | 4 | cell-based format | Scientific Literature | ||
| 12. | ALA4195637 | F | Antiviral activity against Ebolavirus isolate Kikwit infected in human HeLa cells assessed as inhibition of viral infection pretreated for 2 hrs before viral infection and measured after 48 hrs by EboV GP immunostaining based method | Ebolavirus | 4 | cell-based format | Scientific Literature | ||
| 13. | ALA5098248 | B | Inhibition of NPC1/VSV pseudotyped Ebola Viral Glycoprotein protein-protein interaction | Ebolavirus | 2 | assay format | Scientific Literature | ||
| 14. | ALA5098250 | F | Antiviral activity against Ebola virus makona | Ebolavirus | 2 | organism-based format | Scientific Literature | ||
| 15. | ALA5118632 | F | Antiviral activity against pseudotyped Ebola virus assessed as inhibition of viral entry | Ebola virus sp. | 17 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!